Self-assembled stem cell material composite spheroid as well as preparation method and application thereof

By preparing the self-assembled stem cell material composite spheroids, the cross-linking complex of nucleus pulposus decellularized matrix and titanium carbide nanosheets are used to load TGF-β, the problems of low cell survival rate and difficult differentiation in stem cell therapy are solved, and the intervertebral disc is realized The efficient regeneration and microenvironment regulation provides new treatment options.

CN118949133AActive Publication Date: 2024-11-15TIANJIN UNIV +1
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202410936287.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-15
Estimated Expiration
2044-07-12

AI Technical Summary

Technical Problem

The existing stem cell treatment plans have problems such as low cell survival rate, difficulty in controlling differentiation, limited nutritional diffusion and side effects when treating intervertebral disc degeneration, making it difficult to achieve effective microenvironment regulation and efficient tissue regeneration and repair.

Method used

The preparation method of self-assembled stem cell material composite spheroids is used to separate stem cells by tissue adherence method, and cross-link and complex with nucleus pulposus decellularized matrix and titanium carbide nanosheets to load TGF-β to form factor-carrying nanosheet solutions to promote stem cells Proliferation and differentiation provide a per-natural microenvironment and improve oxidative stress and inflammation.

Benefits of technology

It improves the survival rate and controllability of stem cells, enhances the repair ability of intervertebral discs, provides better clinical application prospects, and provides new ideas for the treatment of degenerate intervertebral discs and other degenerative diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004941429210000011
    Figure HDA0004941429210000011
  • Figure HDA0004941429210000012
    Figure HDA0004941429210000012
  • Figure HDA0004941429210000021
    Figure HDA0004941429210000021
Patent Text Reader

Abstract

The invention relates to the technical field of regenerative medicine, in particular to a self-assembled stem cell material composite spheroid and a preparation method and application thereof. The preparation method comprises the following steps: preparing a primary mesenchymal stem cell suspension; taking animal tissues and performing decellularization treatment to prepare a decellularized matrix particle suspension; mixing and incubating the nanosheet solution and a TGF-beta solution to obtain a factor-loaded nanosheet solution; uniformly mixing the factor-loaded nanosheet solution and the acellular matrix particle suspension, and performing cross-linking compounding to obtain cross-linked composite particles; and carrying out mixed culture on a suspension of the cross-linked composite particles and a stem cell suspension to obtain the self-assembled stem cell material composite spheroid. The self-assembled stem cell material composite spheroid is high in survival rate and controllable in differentiation after being implanted into the intervertebral disc, has a good clinical application prospect, and provides a new thought for treatment of degenerative intervertebral disc and other degenerative diseases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of regenerative medicine, and in particular to a self-assembled stem cell material composite spheroid and a preparation method and application thereof. Background Art

[0002] Low back pain is a very common musculoskeletal disease in clinical practice and the main cause of disability. Intervertebral disc degeneration is unanimously considered to be a major factor causing low back pain and is closely related to the severity of pain. At present, the treatment of intervertebral disc degeneration in clinical practice includes conservative therapy and surgical therapy. However, these treatments can only relieve the clinical symptoms caused by protrusion, but cannot reverse degeneration, and patients are still at risk of recurrence. With the development of tissue engineering technology, people have gradually focused on tissue engineering therapy based on stem cells. Since the intervertebral disc is the largest avascular closed tissue in the human body, it has the local characteristics of low oxygen and small number of cells and poor self-repair ability. Therefore, local transplantation of exogenous stem cells has great potential for restoring the structure and function of the intervertebral disc. However, stem cell therapy for intervertebral disc degeneration is still limited by the low cell survival rate caused by the degenerative microenvironment and the difficulty in controlling the directed differentiation of stem cells themselves. Therefore, the use of tissue engineering methods combined with biomaterials and growth factors to reshape the microenvironment for stem cell survival has important research and clinical significance for giving full play to the therapeutic effect of stem cells and realizing the regeneration and repair of intervertebral discs or other damaged tissues.

[0003] In recent years, stem cell therapy has been mainly focused on simple two-dimensional stem cell injection, or the use of a variety of biomaterial scaffold-based or scaffold-free tissue engineering methods to promote the development of stem cell therapy. Although certain effects have been achieved, there are still some obstacles and challenges to achieve the regeneration and repair of degenerative intervertebral discs, such as low retention of two-dimensional stem cells after injection. In tissue engineering methods based on biomaterial scaffolds, natural or synthetic hydrogel materials are widely used for cell loading due to their adjustable mechanical properties, injectability and good cell compatibility. However, hydrogel-based stem cell culture may hinder cell-to-cell interactions and three-dimensional cell aggregation, which is not conducive to the regeneration and repair of nucleus pulposus and cartilage or the degradation of biological scaffolds to produce toxic side effects. Scaffold-free tissue engineering technologies, such as three-dimensional stem cell spheres and two-dimensional stem cell sheets assembled from stem cells, effectively retain cell-to-cell interactions during tissue regeneration and avoid the side effects of exogenous scaffold materials in vivo, and have gradually attracted attention in recent years. However, the three-dimensional stem cell spheres obtained by these traditional stem cell assembly methods still have some problems, including limited nutrient diffusion, core necrosis, uncontrollable stem cell differentiation, and low ability to regulate inflammation and inhibitory microenvironment at the site of tissue injury.

[0004] Therefore, existing stem cell treatment programs all have obvious defects. It is very necessary to develop a new preparation method that can fully tap the therapeutic potential of stem cells, achieve effective microenvironment regulation, and achieve high survival rate and efficient directional differentiation of stem cells in the body. Summary of the invention

[0005] In order to solve the deficiencies of the above technical solutions, the object of the present invention is to provide a method for preparing a self-assembled stem cell material composite spheroid.

[0006] Another object of the present invention is to provide a self-assembled stem cell material composite spheroid obtained by the above preparation method.

[0007] Another object of the present invention is to provide an application of the self-assembled stem cell material composite spheroid.

[0008] The purpose of the present invention is achieved through the following technical solutions.

[0009] The present invention provides a method for preparing a self-assembled stem cell material composite spheroid, comprising the following steps:

[0010] Step 1, isolating primary mesenchymal stem cells by tissue adhesion method, culturing and digesting them in complete culture medium to obtain a stem cell suspension;

[0011] Step 2, sterilizing and decellularizing the animal tissue to obtain a decellularized matrix (ECM), and then freeze-drying, grinding, resuspending, and filtering to obtain a decellularized matrix microparticle suspension;

[0012] Step 3, mixing and incubating the nanosheet solution with the TGF-β solution to load TGF-β onto the nanosheet to obtain a loaded nanosheet solution, wherein the concentration of the nanosheet solution is 0.1-5 mg / ml, the concentration of the TGF-β solution is 10-500 ng / ml, and the mixing ratio of the nanosheet solution to the TGF-β solution is (0.1-5) ml: (10-500) ng;

[0013] Step 4, mixing the factor-carrying nanosheet solution obtained in step 3 and the decellularized matrix microparticle suspension obtained in step 2 evenly, cross-linking and compounding, and incubating at 4° C. for 12-48 hours to obtain cross-linked composite microparticles, wherein the concentration of the factor-carrying nanosheet solution is 0.1-1 mg / ml, the concentration of the decellularized matrix microparticle suspension is 1-50 mg / ml, and the volume ratio of the factor-carrying nanosheet solution to the decellularized matrix microparticle suspension is (1-10):(1-10);

[0014] Step 5, mixing the suspension of cross-linked composite particles obtained in step 4 with the stem cell suspension in step 1, planting them in a well plate, centrifuging to promote cell aggregation at the bottom of the well, and culturing to obtain self-assembled stem cell material composite spheroids, wherein the concentration of the suspension of cross-linked composite particles is 0.1 to 5 mg / ml, and the concentration of the stem cell suspension is 1 to 10×10 5 / ml, and the volume ratio of the suspension of cross-linked composite particles to the suspension of stem cells is (1-2): (1-10).

[0015] In the above technical solution, further, in step 1, the primary mesenchymal stem cells are primary bone marrow mesenchymal stem cells, primary adipose mesenchymal stem cells or primary umbilical cord mesenchymal stem cells.

[0016] In the above technical solution, further, in step 1, the culture is carried out in an incubator, and the complete stem cell culture medium needs to be replaced every 3 days until the cell confluence is greater than 90%, and the complete stem cell culture medium is DMEM / F12 culture medium containing 10% fetal bovine serum and 1% antibiotics.

[0017] In the above technical solution, further, in the step 1, the primary mesenchymal stem cells are cultured in a cell culture incubator to the 2nd to 5th generations.

[0018] In the above technical solution, further, in step 2, the animal tissue is nucleus pulposus tissue, cartilage tissue, muscle tissue, heart, liver or kidney.

[0019] In the above technical solution, further, in step 2, the disinfection and sterilization is to immerse the animal tissue in 0.1% peracetic acid for 4 hours and then wash it with sterile water or saline.

[0020] In the above technical scheme, further, in step 2, the decellularization treatment is to decellularize the disinfected and sterilized animal tissue with 1% SDS and 1% Triton X-100 for 3 days, wash it with a buffer containing 50U / mL of DNase I and 1U / mL of RNase, and then wash it with sterile water to obtain a decellularized matrix.

[0021] In the above technical scheme, further, in the step 2, the freeze-dried grinding is quick-frozen with liquid nitrogen, then placed in a grinder for 5 to 10 times of sufficient grinding, sterilized by ultraviolet for 1 hour, resuspended with DMEM / F12 basal culture medium, blown and mixed, filtered to obtain a decellularized matrix microparticle suspension, and the particle size of the decellularized matrix microparticle suspension is 20 to 100 μm.

[0022] In the above technical solution, further, in step 3, the mixed incubation is mixing the nanosheet solution and the TGF-β solution, incubating at 4° C. for 12-48 hours, and centrifuging to obtain the factor-loaded nanosheet solution.

[0023] In the above technical solution, further, in step 3, the nanosheets are titanium carbide nanosheets, manganese dioxide nanosheets, graphene nanosheets or black phosphorus nanosheets.

[0024] In the above technical scheme, further, an etching stripping method is used to prepare a titanium carbide nanosheet solution, comprising the following steps: adding Ti3AlC2 powder to an HF solution under stirring to react for 5 hours, centrifuging, repeatedly washing until the pH is 4-5, obtaining a black precipitate, adding TPAOH to mix evenly, centrifuging and washing multiple times until the pH is 7, adding to distilled water, ultrasonicating, centrifuging again, and diluting to obtain a titanium carbide nanosheet solution, wherein the mass fraction of the Ti3AlC2 is 1, the volume fraction of the HF is 20, the volume fraction of the TPAOH is 20, the unit of the volume fraction is ml, and the unit of the mass fraction is g.

[0025] In the above technical solution, further, the dilution is diluted with deionized water to 500 μg / ml.

[0026] In the above technical solution, further, the repeated washing is repeated with distilled water and ethanol, the mixing time is 24 hours, the mixing temperature is room temperature, the centrifugal rate of the multiple centrifugations is 5000 rpm, and the ultrasonic time is 2 hours.

[0027] In the above technical solution, further, in step 5, the well plate is a low-adhesion U-shaped 96-well plate, the centrifugation rate is 1000 rpm, the time is 3 min, the culture temperature is 37° C., and the culture time is 12 to 72 h.

[0028] The present invention also provides a self-assembled stem cell material composite spheroid, which is prepared by the above preparation method.

[0029] In the above technical solution, further, the above self-assembled stem cell material composite spheroid is used in the treatment of intervertebral disc degeneration, and the self-assembled stem cell material composite spheroid is injected in situ to supplement the nucleus pulposus cells.

[0030] Compared with the prior art, the present invention has the following beneficial effects:

[0031] 1. The self-assembled stem cell material composite spheroids of the present invention are composited with nucleus pulposus decellularized matrix particles, thereby providing a quasi-natural microenvironment for the self-assembled stem cell material composite spheroids and promoting the proliferation and cartilage-like differentiation of the self-assembled stem cell material composite spheroids; at the same time, the present invention uses titanium carbide nanosheets to remove reactive oxygen species (ROS), and loads transforming growth factor-β (TGF-β) on the titanium carbide nanosheets, together creating a physical microenvironment for the growth and differentiation of the self-assembled stem cell material composite spheroids, thereby improving the oxidative microenvironment of the degenerative intervertebral disc.

[0032] 2. The intervertebral disc is the largest avascular tissue in the human body, with a small number of cells and poor self-repair ability. Tissue repair cannot be achieved by relying solely on the regenerative ability of endogenous cells. Therefore, the present invention exposes the intervertebral disc of rats and supplements the nucleus pulposus cells by injecting self-assembled stem cell material composite spheroids to improve the repair ability of the intervertebral disc. The self-assembled stem cell material composite spheroids of the present invention have a high survival rate when implanted into the intervertebral disc, and the differentiation is controllable. The self-assembled stem cell material composite spheroids of the present invention have good clinical application prospects and provide new ideas for the treatment of degenerative intervertebral discs and other degenerative diseases.

[0033] 3. The nucleus pulposus decellularized matrix of the present invention is derived from the extracellular matrix of natural tissue (nucleus pulposus tissue in fresh bovine vertebrae), which retains some protein components and biochemical clues of natural tissue and can be well used to reconstruct the stem cell microenvironment; the titanium carbide nanosheets of the present invention have excellent ROS scavenging and anti-inflammatory effects, and can well improve the oxidative stress microenvironment of degenerated intervertebral discs; in addition, the high surface area of ​​the titanium carbide nanosheets can efficiently load TGF-β and continuously release it as it degrades, and is an excellent drug delivery carrier; the titanium carbide nanosheets and the nucleus pulposus decellularized matrix particles are cross-linked and composited, which, on the one hand, prevents cell endocytosis, and on the other hand, improves the overall mechanical strength of the cross-linked composite particles and slows down the degradation rate of the ECM particles. The two cooperate with each other to create conditions for the survival and differentiation of the self-assembled stem cell material composite spheroids, thereby promoting the regeneration and repair of intervertebral disc degeneration. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 The pictures are of natural nucleus pulposus and decellularized nucleus pulposus matrix and the results of DAPI staining;

[0035] Figure 2 To determine the DNA content of natural nucleus pulposus and acellular matrix of nucleus pulposus;

[0036] Figure 3 The difference in protein composition between natural nucleus pulposus and acellular nucleus pulposus matrix;

[0037] Figure 4 The biocompatibility of the acellular matrix particles of nucleus pulposus;

[0038] Figure 5 TEM morphology of titanium carbide nanosheets;

[0039] Figure 6 is the Zeta potential diagram of titanium carbide nanosheets;

[0040] Figure 7 is the particle size distribution diagram of titanium carbide nanosheets;

[0041] Figure 8 This is a graph showing the biocompatibility and concentration screening of titanium carbide nanosheets;

[0042] Fig. 9 is the antioxidant activity diagram of titanium carbide nanosheets;

[0043] Fig.10 TEM images of self-assembled stem cell material composite spheroids and stem cell spheroids;

[0044] Fig.11 The expression of stem cell cartilage differentiation markers in different material composite ball groups;

[0045] Fig.12 Survival and differentiation of composite spheroids after implantation in vivo. DETAILED DESCRIPTION

[0046] The technical solution of the present invention is further described below in conjunction with specific embodiments.

[0047] Example 1

[0048] A method for preparing a self-assembled stem cell material composite spheroid comprises the following steps:

[0049] Step 1: Isolate primary bone marrow mesenchymal stem cells using tissue adhesion method and culture them in a cell culture incubator in complete culture medium to obtain a concentration of 4×10 5 The cell culture incubator needs to replace the complete stem cell culture medium every 3 days, and the cells are cultured to the third generation until the cell confluence is greater than 90%, and the complete stem cell culture medium is DMEM / F12 containing 10% fetal bovine serum (FBS) and 1% antibiotics (PS).

[0050] The specific process of isolating primary bone marrow mesenchymal stem cells by tissue adhesion method is as follows: rats are killed by dislocation, soaked in 75% ethanol for 20 minutes, bilateral femurs and tibias are aseptically separated on a sterile operating table, DMEM / F12 basal culture medium is drawn with a 10 ml syringe to flush the bone marrow of the rats from the bone marrow cavity of the tibia and femur, centrifuged at 1000 rpm for 5 minutes, the supernatant is discarded, and red blood cell lysis solution is added to the cell pellet to lyse the red blood cells, the remaining bone marrow cells are centrifuged again, resuspended in DMEM / F12 complete culture medium supplemented with 10% FBS and 1% PS (penicillin and streptomycin), placed in a carbon dioxide incubator for routine culture, and the cells are digested and passaged with trypsin after adhesion, and the third generation bone marrow mesenchymal stem cells are taken for subsequent experiments.

[0051] Step 2, the nucleus pulposus tissue is sterilized and then decellularized to obtain the nucleus pulposus decellularized matrix, which is then freeze-dried, ground, sterilized, resuspended, and filtered to obtain the nucleus pulposus decellularized matrix microparticle suspension, wherein the sterilization is performed in a 0.1% peracetic acid solution for 4 hours and washed with sterile water; the decellularization is performed in a sterile 1% (w / v) SDS solution and 1% Triton X-100 solution is shaken on a shaker at room temperature to decellularize, the solution is changed every 4 hours for three days, and then washed with sterile water until there is no foam; washed with Tris-HCl buffer containing 50U / mL of DNase I and 1U / mL of ribonuclease A at 37°C, and then washed with sterile water; the freeze-dried grinding is quick-frozen with liquid nitrogen, then loaded into a grinding tube, put into a grinder and ground at low temperature for 5 to 10 times, ultraviolet disinfection and sterilization for 1 hour, resuspended with DMEM / F12 basal culture medium, fully blown and mixed, and filtered through a 70μm pore size filter to obtain a nucleus pulposus decellularized matrix particle suspension (particle size less than 70μm).

[0052] Step 3, mixing and incubating the titanium carbide nanosheet solution and the TGF-β solution to load TGF-β onto the titanium carbide nanosheets to obtain a factor-loaded nanosheet solution, wherein the concentration of the titanium carbide nanosheet solution is 800 μg / ml, and the concentration of the TGF-β solution is 500 ng / ml; the mixing ratio of the nanosheet solution and the TGF-β solution is 1 ml:500 ng; the mixed incubation is to mix the titanium carbide nanosheet solution and the TGF-β solution, incubate at 4°C for 24 hours, centrifuge at 12000 rpm for 10 minutes, discard the supernatant, take the precipitate and resuspend it in distilled water to obtain the factor-loaded nanosheet solution.

[0053] The titanium carbide nanosheet solution is prepared by an etching stripping method, comprising the following steps: under magnetic stirring, 1 g of Ti3AlC2 powder is added to 20 ml of HF solution (40 wt.%) to react for 5 hours, centrifuged, repeatedly washed with distilled water and anhydrous ethanol to a pH of 4 to 5 to obtain a black precipitate, 20 ml of TPAOH (25 wt.%) is added at room temperature and mixed for 24 hours, centrifuged and washed multiple times at 5000 rpm to a pH of 7, added to distilled water, ultrasonicated for 2 hours, centrifuged at 3500 rpm for 1 hour, and diluted with deionized water to 500 μg / ml to obtain a titanium carbide nanosheet solution.

[0054] Step 4: Evenly mix the titanium carbide factor-carrying nanosheet solution and the nucleus pulposus decellularized matrix microparticle suspension, incubate at 4°C for 24 hours to achieve cross-linking and composite, and obtain cross-linked composite microparticles, wherein the concentration of the factor-carrying nanosheet solution is 0.5 mg / ml, the concentration of the decellularized matrix microparticle suspension is 10 mg / ml, and the volume ratio of the titanium carbide factor-carrying nanosheet solution to the nucleus pulposus decellularized matrix microparticle suspension is 1:2.5. Step 5: Mix 20 μl of the suspension of cross-linked composite microparticles with a concentration of 5 mg / ml and 20 μl of the suspension of cross-linked composite microparticles with a concentration of 4×10 5 The cells were mixed with a stem cell suspension of 100 μg / ml and seeded in a low-adhesion U-shaped 96-well plate. 150 μl of DMEM / F12 complete medium was added and centrifuged at 1000 rpm for 3 min to promote cell aggregation at the bottom of the well. The plates were cultured in an incubator at 37°C for 24 h to obtain self-assembled stem cell material composite spheroids.

[0055] Comparative Example 1

[0056] The concentration of 20 μl is 4 × 10 5 The third-generation bone marrow mesenchymal stem cell suspension obtained in step 1 of Example 1 was seeded in a low-adhesion U-shaped 96-well plate, supplemented with 150 μl of DMEM / F12 complete medium, centrifuged at 1000 rpm for 3 min to promote cell aggregation at the bottom of the well, and cultured in an incubator at 37° C. for 24 h to obtain stem cell spheroids, wherein the bone marrow mesenchymal stem cells are the third-generation bone marrow mesenchymal stem cells described in the example.

[0057] The decellularized nucleus pulposus decellularized matrix obtained in Example 1 was characterized by taking a small piece of the decellularized nucleus pulposus matrix and fixing it in 4% paraformaldehyde for 5 h to obtain a fixed tissue, then dehydrating the fixed tissue with a 30% sucrose solution for 24 h, embedding it with OCT, freezing it, cutting it into 8 μm slices and storing it at -20°C, and examining the removal of cell nuclei in the nucleus pulposus tissue before (nucleus pulposus tissue) and after (nucleus pulposus decellularized matrix) decellularization by DAPI staining, and quantitatively analyzing the DNA content in the natural nucleus pulposus tissue and the decellularized nucleus pulposus matrix by a DNA quantitative kit, as shown in FIG. Figure 1 and Figure 2 shown.

[0058] Depend on Figure 1 and Figure 2 It can be seen that the nucleus pulposus tissue becomes fluffy and swollen after decellularization, the cell nucleus is basically removed, and the detected DNA content is also lower than 50ng / mg, indicating that the decellularization method has a good decellularization effect and meets the application requirements of low immunogenicity.

[0059] The nucleus pulposus decellularized matrix obtained in Example 1 was subjected to proteomic identification: its main processes include protein enzymatic hydrolysis, LC-MS / MS analysis, database retrieval, data analysis, etc. This test was completed and the experimental result report was obtained by Shanghai Baipu Biotechnology Co., Ltd. Figure 3 shown.

[0060] Depend on Figure 3 It can be seen that the number of protein types in the nucleus pulposus decellularized matrix is ​​slightly lower than that in the natural nucleus pulposus tissue, and the common protein components account for the vast majority, indicating that the decellularization treatment of the present invention can well retain the protein components in the original nucleus pulposus tissue, making it have good biological activity.

[0061] Cytocompatibility evaluation:

[0062] The third generation bone marrow mesenchymal stem cells were cultured at 3×10 4 The cells were seeded at a density of 100 μg / well in a 96-well low-adhesion plate, and then different concentrations of nucleus pulposus decellularized matrix microparticle suspension were added (the concentrations of nucleus pulposus decellularized matrix microparticle suspension were 50, 100, 200, and 400 μg / ml, respectively). The plates were placed in a 37°C incubator to incubate the cells to form cell spheres. After 24 hours, the plates were removed, 10 μl of CCK8 working solution was added, and the cells were incubated at 37°C for 2 hours. The absorbance was detected using an enzyme marker. The results are shown in Figure 2. Figure 4 As shown. Figure 4 It can be seen that adding different concentrations of nucleus pulposus acellular matrix particles to bone marrow mesenchymal stem cells not only did not produce cytotoxicity, but was also significantly different from the control group ( Figure 4 Compared with the group with an ECM concentration of 0, the proliferation of bone marrow mesenchymal stem cells was significantly promoted, especially at a concentration of 100 μg / ml, the promoting effect was the most obvious, indicating that the nucleus pulposus acellular matrix particles have excellent cell compatibility. The above proteomic identification results also explain the source of the biological activity of the nucleus pulposus acellular matrix particles.

[0063] Microstructure of titanium carbide nanosheets:

[0064] The titanium carbide nanosheet solution was dropped onto the copper mesh sample stage and dried. The drying time was about 1 hour. After the drying was completed, the titanium carbide nanosheet was put on the machine and the microscopic morphology of the titanium carbide nanosheet was observed and photographed using a transmission electron microscope (TEM). Figure 5As shown by Figure 5 It can be seen that the present invention successfully prepared ultra-thin single-layer lamellar titanium carbide nanosheets by etching and stripping method.

[0065] Potential and particle size of titanium carbide nanosheets:

[0066] The titanium carbide nanosheet solution was diluted with ultrapure water and then poured into a cuvette. The potential and particle size were measured using a nano-laser particle size analyzer. The results are as follows: Figure 6 and Figure 7 As shown by Figure 6 and Figure 7 It can be seen that titanium carbide nanosheets are negatively charged with a potential value of about 20 mV, and their particle sizes are mainly distributed in the range of 100-400 nm, indicating that titanium carbide nanosheets have been successfully prepared.

[0067] Cytocompatibility of Titanium Carbide Nanosheets:

[0068] Bone marrow mesenchymal stem cells were cultured at 3×10 4 The cells were planted at a density of 100 μg / well in a 96-well low-adhesion plate, and different concentrations of titanium carbide nanosheet solutions (concentrations were 10, 20, 40, 80, and 160 μg / ml) were added to the culture medium. The cells were placed in a 37°C incubator and incubated to form cell spheres. The plate was taken out at the same time point on the first and second days after sphere formation, 10 μl of CCK8 working solution was added, and the cells were incubated at 37°C for 2 h. The absorbance was detected by an enzyme reader. The results are shown in the figure. Figure 8 As shown by Figure 8 It can be seen that the addition of different concentrations of titanium carbide nanosheets has different effects on the activity of bone marrow mesenchymal stem cells. High concentrations of titanium carbide nanosheets added to bone marrow mesenchymal stem cells show obvious cytotoxicity as the culture time increases, while low concentrations of titanium carbide nanosheets have little effect on the activity of bone marrow mesenchymal stem cells.

[0069] Antioxidant Activity of Titanium Carbide Nanosheets:

[0070] Bone marrow mesenchymal stem cells were used to test the ability of titanium carbide nanosheets to remove ROS in an oxidative microenvironment. Specifically, bone marrow mesenchymal stem cells were placed at 3×10 4 The ratio of cells was planted in a low-adhesion u-shaped 96-well plate and incubated with different concentrations of titanium carbide nanosheets (20, 40 μg / mL) to form composite cell spheroids. After the spheroids were formed, they were treated with 100 μM H2O2 for 2 h, 10 μl of CCK8 working solution was added, and incubated at 37°C for 2 h. The absorbance was detected by an enzyme reader. The results are shown in Fig. 9 As shown by Fig. 9It can be seen that H2O2 stimulation caused a significant increase in the mortality rate of bone marrow mesenchymal stem cells, while the addition of titanium carbide nanosheets at different concentrations significantly increased the survival rate of bone marrow mesenchymal stem cells, indicating that titanium carbide nanosheets have good antioxidant properties, play an effective protective role, and promote the survival of bone marrow mesenchymal stem cells.

[0071] The self-assembled stem cell material composite spheroids prepared in Example 1 and the stem cell spheroids prepared in Comparative Example 1 were fixed in 2.5% v / v glutaraldehyde solution, respectively, and then dehydrated in 50%, 70%, 100%, and 100% ethanol gradients, with each concentration lasting 10 minutes. After dehydration, the self-assembled stem cell material composite spheroids and stem cell spheroids were taken out of the 100% ethanol and placed in a supercritical dryer for critical point drying. The drying time was about 1 hour. After drying, they were taken out, fixed on the sample stage, sprayed with gold, and the microscopic morphology was observed using a scanning electron microscope (SEM) at an accelerating voltage of 5kV. The results are shown in Figure 2. Fig.10 As shown. Fig.10 It can be seen that both the self-assembled stem cell material composite spheroid and the stem cell spheroid are dense and compact. The stem cell spheroid has obvious cell clusters and less extracellular matrix secretion, while the self-assembled stem cell material composite spheroid has a large amount of extracellular matrix secretion, which integrates the nucleus pulposus decellularized matrix with titanium carbide nanosheets and cells without obvious boundaries, showing better integration. This shows that the addition of bone marrow nucleus decellularized matrix and titanium carbide nanosheets in the self-assembled stem cell material composite spheroid improves the overall vitality of stem cells and is conducive to providing a good microenvironment for stem cells.

[0072] Evaluation of the self-assembled stem cell material composite spheroid prepared in the present invention in promoting stem cell differentiation:

[0073] We used the fluorescence quantitative PCR method to detect the expression of cartilage marker genes in different cell spheroid groups: pure stem cell sphere group (BMSC), titanium carbide nanosheet composite stem cell sphere group (NSs+BMSC), TGF-β factor composite stem cell sphere group (TGF+BMSC), factor-loaded nanosheet composite stem cell sphere group (NSs-TGF+BMSC), matrix microparticle composite stem cell sphere group (ECM+BMSC), factor-loaded and nanosheet matrix microparticle composite stem cell sphere group (ECM-NSs-TGF+BMSC). Each group was prepared according to the method of Example 1 with 3×10 bone marrow mesenchymal stem cells per well. 4The ratio of cells was planted in a low-adhesion u-shaped 96-well plate. The difference between each group was that the aforementioned titanium carbide nanosheets (NSs+BMSC group), the aforementioned TGF-β factor (TGF+BMSC), the aforementioned factor-carrying nanosheets (NSs-TGF+BMSC), the aforementioned matrix particles (ECM+BMSC), and the aforementioned matrix particles of the factor-carrying nanosheets (ECM-NSs-TGF+BMSC) were added to obtain spheroids according to the different groups, and the spheroids were incubated at 37°C for 7 days. Specifically, the cell spheroids of each group were first collected, 1 ml of TRIZOL was added to each group, and then transferred to an EP tube for RNA extraction according to the instructions of the RNA extraction kit, and then the RNA concentration was determined by Nanodrop. Next, the RNA was reverse transcribed on the machine to obtain cDNA, and finally primers and fluorescent dyes were added to the machine for detection. The results are shown in the following figure. Fig.11 As shown. Fig.11 It can be seen that whether it is nucleus pulposus decellularized matrix particles or titanium carbide nanosheets, their addition to the cell spheres can more or less increase the expression of differentiation genes, and the co-addition of the two and the loading of factors can synergistically promote stem cell differentiation. The expression trends of differentiation markers in the early, middle and late stages are consistent. This confirms the differentiation-promoting effect of matrix particles and titanium carbide nanosheets.

[0074] In vivo implantation evaluation:

[0075] First, a rat caudal disc degeneration model was constructed. Specifically, about 20 rat discs were randomly divided into 6 groups: normal control group, defect group, pure cell sphere group, ECM+cell sphere group, ECM-NSs+cell sphere group, and ECM-NSs-TGF+cell sphere group, with n=6 discs in each group. The rats were anesthetized by intraperitoneal injection of sodium pentobarbital, the skin of the rat tail was cut to expose the disc, and a sterile 20-gauge needle was inserted into the center of the nucleus pulposus to aspirate the nucleus pulposus tissue to induce disc degeneration. Subsequently, an equal amount of cell spheres with GFP fluorescence from each group was injected into each nucleus pulposus with a microsyringe. PBS was injected into the defect group as a control. The skin was then sutured and the rats were fed routinely after iodine disinfection.

[0076] One week later, the intervertebral discs were removed and sliced, and the GFP fluorescence signals in different groups were observed under a confocal microscope. Fig.12It can be seen that different cell ball groups retain different degrees of fluorescence signals after injection. With the addition of composite components, the connection in the cell ball gradually becomes tighter, the loss rate after injection gradually decreases, and the fluorescence signal gradually increases. The group of the composite stem cell ball group (ECM-NSs-TGF+cell ball) loaded with factor titanium carbide nanosheets and nucleus pulposus decellularized matrix microparticles shows the highest fluorescence area retention. At the same time, in the cell ball group with ECM composite, not only the enhanced fluorescence signal is observed, but also the partial residue of the cell ball can be seen, indicating that the composite ball is still not completely degraded one week after injection and remains in place, which further confirms the local retention ability of the composite ball in the harsh intervertebral disc environment, and exerts a long-term therapeutic effect through a suitable degradation rate.

[0077] The present invention is described above by way of example. It should be noted that, without departing from the core of the present invention, any simple deformation, modification or other equivalent replacement that can be made by those skilled in the art without inventive effort falls within the protection scope of the present invention.

Claims

1. A method for preparing a self-assembled stem cell material composite spheroid, characterized in that: The following steps are involved: Step 1, preparing a primary mesenchymal stem cell suspension; Step 2, decellularizing the animal tissue to obtain a decellularized matrix, and then preparing a decellularized matrix microparticle suspension; Step 3, mixing and incubating the nanosheet solution with the TGF-β solution to obtain a factor-carrying nanosheet solution, wherein the concentration of the nanosheet solution is 0.1-5 mg / ml, the concentration of the TGF-β solution is 10-500 ng / ml, and the mixing ratio of the nanosheet solution to the TGF-β solution is (0.1-5) ml: (10-500) ng; Step 4, uniformly mixing the factor-carrying nanosheet solution obtained in step 3 and the decellularized matrix microparticle suspension obtained in step 2, cross-linking and compounding to obtain cross-linked composite microparticles, wherein the concentration of the factor-carrying nanosheet solution is 0.1-1 mg / ml, the concentration of the decellularized matrix microparticle suspension is 1-50 mg / ml, and the volume ratio of the factor-carrying nanosheet solution to the decellularized matrix microparticle suspension is (1-10):(1-10); Step 5, mixing the suspension of cross-linked composite particles obtained in step 4 with the stem cell suspension in step 1, culturing, and obtaining self-assembled stem cell material composite spheroids, wherein the concentration of the suspension of cross-linked composite particles is 0.1 to 5 mg / ml, and the concentration of the stem cell suspension is 1 to 10×10 5 / ml, and the volume ratio of the suspension of cross-linked composite particles to the suspension of stem cells is (1-2):(1-10).

2. The preparation method according to claim 1, characterized in that: In step 1, primary mesenchymal stem cells are separated by tissue adhesion method and cultured in complete culture medium until the cell confluence is greater than 90%; the complete stem cell culture medium is DMEM / F12 culture medium containing 10% fetal bovine serum and 1% antibiotics.

3. The preparation method according to claim 1, characterized in that: In the step 1, the primary mesenchymal stem cells are cultured to the second to fifth generations, and the primary mesenchymal stem cells are primary bone marrow mesenchymal stem cells, primary adipose mesenchymal stem cells or primary umbilical cord mesenchymal stem cells.

4. The preparation method according to claim 1, characterized in that: In step 2, the animal tissue is nucleus pulposus tissue, cartilage tissue, muscle tissue, heart, liver or kidney; The decellularization treatment comprises decellularizing the sterilized animal tissue with 1% SDS and 1% Triton X-100, washing it with a buffer solution containing 50U / mL DNase I and 1U / mL RNase, and then washing it with sterile water to obtain a decellularized matrix; the particle size of the obtained decellularized matrix microparticle suspension is 20 to 100 μm.

5. The preparation method according to claim 1, characterized in that: In step 3, the mixed incubation is to mix the nanosheet solution and the TGF-β solution, incubate at 4°C for 12-48 hours, and centrifuge to obtain the factor-loaded nanosheet solution; and the cross-linking compounding in step 4 is to incubate at 4°C for 12-48 hours.

6. The preparation method according to claim 1, characterized in that: In step 3, the nanosheets are titanium carbide nanosheets, manganese dioxide nanosheets, graphene nanosheets or black phosphorus nanosheets.

7. The preparation method according to claim 6, characterized in that: Titanium carbide nanosheets were prepared by etching and stripping method.

8. The preparation method according to claim 1, characterized in that: In step 5, the cross-linked composite microparticle suspension is mixed with the stem cell suspension and then planted in a well plate, centrifuged, and cultured at 37° C. for 12-72 hours. The well plate is a low-adhesion U-shaped 96-well plate.

9. A self-assembled stem cell material composite spheroid prepared by the preparation method according to any one of claims 1 to 8.

10. Use of the self-assembled stem cell material composite spheroid according to claim 9 in preparing a material for treating intervertebral disc degeneration.

Citation Information

Patent Citations

  • Nerve fusion agent for treating peripheral nerve injury, and preparation method and application thereof

    CN109260456A

  • Guided Bone Regeneration (GBR) biological membrane and preparation method

    CN111330080A

  • Method and system for separating, culturing and amplifying human umbilical cord mesenchymal stem cells

    CN113249317A

  • Neural stem cell culture and detection integrated platform based on MXene-Fe3O4 and application thereof

    CN115558643A

  • Scaffold material for mesenchymal stem cell in-vitro osteogenesis induced differentiation and application thereof

    CN115572706A